REQUEST A DEMO
Total
USD $0.00
Search more companies

Sense & Science S A S (Colombia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Sense & Science S A S Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Sense and Science, founded in 2018 and headquartered in Bogotá, Colombia, is a leading company in the healthcare technologies industry. With a local presence in Brazil, Chile, Colombia, and the United States, the company specializes in market access strategies for pharmaceutical products and medical devices in Latin America. Sense and Science offers tailored solutions for established pharmaceutical companies and biotechnology/gene therapy startups, with a portfolio of over 100 HTAs. The company has completed over 450 projects in the last 5 years and employs 1-10 people.

Headquarters
Carrera 23 122 88 Apartamento 203
Bogota D.C.; Bogota D.C; Postal Code: 1012

Contact Details: Purchase the Sense & Science S A S report to view the information.

Basic Information
Total Employees:
Purchase the Sense & Science S A S report to view the information.
Financial Auditors:
Purchase the Sense & Science S A S report to view the information.
Incorporation Date:
January 06, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Sense & Science S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-43.39%
Total operating revenue
-43.39%
Operating Profit/Loss (EBIT)
58.29%
Net Profit/Loss for the Period
60.66%
Total Assets
25.17%
Total Equity
35.57%
Operating Profit Margin (ROS)
35.5%
Net Profit Margin
25.79%
Return on Equity (ROE)
6.43%
Quick Ratio
-1.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?